Please login to the form below

Not currently logged in
Email:
Password:

Burson-Marsteller appoint new EMEA health MD

Kate Hawker joins the agency from InforMed

Burson-Marsteller, Kate Hawker

Burson-Marsteller has appointed Kate Hawker as the new MD and chair of its EMEA and UK healthcare divisions.

“Kate is an excellent, and welcome, addition to Burson-Marsteller's outstanding group of EMEA practice chairs,” said Jeremy Galbraith, CEO of Burson-Marsteller EMEA.

“She brings the healthcare expertise and individual creativity that clients justifiably expect from a leading global agency and I am delighted she is joining us.”

She joins the agency after three years as business development director for InforMed, following the acquisition of her start-up medical communications company Medea.

During her 25-year career Hawker has directed pan-European and UK medical communications and PR programmes, having worked on campaigns for GSK, Baxter, Takeda, Boehringer-Ingelheim, Bristol Meyer Squibb, MSD and others.

She has also been a director and partner at Fleishman-Hillard, director at OCC and associate director for Shire Health International.


Commenting on her appointment, Hawker said: “I'm delighted to be joining Burson-Marsteller, an agency with a stand-out reputation for delivering integrated communications campaigns on a UK, EMEA and global level. I'm looking forward to working with a great team both in the UK and across EMEA.”

20th November 2012

From: Marketing, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...